ClinicalTrials.gov
public full text
Public Domain
Intravitreal Celecoxib for Chronic Uveitis
Intraocular delivery of celecoxib will be an effective means to treat inflammation and macular edema and prevent structural complications and vision loss in patients with chronic inflammation or macular edema who are unable to tolerate corticosteroids due to their side effects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular Degeneration#910203
- Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS#825531
- Evaluation of Neovis® Total Multi Versus Systane® Balance on Ocular Dryness Associated With Meibomian Gland Dysfunction#1093776
- Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis#887114
- Macula- Versus Disc-Centered Fundus Photography: Performance in Age-Prediction and Disease Associations.#295161
Record · ID 1171992
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive